Kurser indlæses...

Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

Terveystalo Q3: revenue falls, margins and cash flow improve – stock plunges

Terveystalo reported a 5.2% decline in revenue for Q3 2025 to €280.4m, while adjusted EBIT remained almost stable at €26.8m and the adjusted EBIT margin rose to 9.5%. Earnings per share climbed 9.7% to €0.13 and operating cash flow increased 32% to €54.5m. Causes of the revenue decline include reduced outsourcing contracts, fewer occupational health services and lower sickness rates; the business in Sweden remains loss-making but is improving. Management confirmed the full-year guidance for adjusted EBIT of €155–165m; the share fell 8.25% to €9.23 after the release. » Mere på de.investing.com
Terveystalo share falls after 5% revenue decline in third quarter

Terveystalo reported a 5% revenue decline in Q3 2025 but maintained its adjusted EBIT guidance of €155–165m. The adjusted EBIT margin and operating cash flow improved, while the leverage ratio stood at 2.1. The stock reacted negatively, falling 8.15% in pre-market trading to $9.24. The company continues to invest in digital health services and expects growth in connected employees through 2026. » Mere på de.investing.com
Terveystalo reports record profitability in Q2 2025, shares fall despite strong EBIT

Terveystalo achieved record profitability in the second quarter of 2025 with EBIT of €36.7 million and a margin of 11.4%, but saw a slight decline in revenue compared to the previous year. The stock fell 7.35% in pre-market trading as investors expressed concerns about the revenue drop and weakness in the occupational health segment, despite strong profitability. The company maintains its full-year EBIT guidance and continues to focus on digital transformation and technological innovation. » Mere på de.investing.com

Historisk udbytte Udbytte

Alle nøgletal for udbytte Alle nøgletal

I 2026 har Terveystalo allerede udloddet 0,64 € i udbytte. Den seneste udlodning fandt sted i oktober.

Virksomhedstal

I det seneste kvartal havde Terveystalo en omsætning på 257,32 mio. € og et nettoresultat på 5,38 mio. €

(EUR)	september 2026	YoY
Omsætning	257,32 mio.	8,40 %
Bruttofortjeneste	45,02 mio.	17,69 %
Nettoresultat	5,38 mio.	66,83 %
EBITDA	41,01 mio.	15,60 %

Fundamentale data

Nøgletal	Værdi
Markedsværdi	812,03 mio. €
Antal aktier	126,81 mio.
Højeste/laveste i 52 uger	11,53 € - 6,40 €
Udbytteafkast	10,27 %
Udbytte TTM	0,64 €
Beta	0,37
P/E (PE Ratio)	13,74
PEG (PEG Ratio)	-0,37
K/I (PB Ratio)	1,47
P/S (PS Ratio)	0,66

Virksomhedsprofil

Terveystalo Oyj leverer arbejdsmedicinske sundhedsydelser i Finland. Virksomheden tilbyder almen praksis og speciallægelig behandling, diagnostik, ambulant kirurgi, tandpleje og andre tilgrænsende ydelser; samt outsourcingydelser, bemandingsydelser, børnevelfærdsydelser, mundsundhed, laboratorie, billeddiagnostik, velvære, dagkirurgi, sundhedsoutsourcing, sundhedsbemanding samt primær- og specialistsundhedsydelser. Virksomheden tilbyder også en pakke digitale sundhedsydelser og kliniske forskningsydelser. Virksomheden betjener privatpersoner, virksomheder og lokalsamfund, forsikringsselskaber og offentlige kunder. Den driver 360 klinikker, herunder 18 hospitalsenheder og 38 tandklinikker, samt 73 Rela hierojat massageterapienheder. Virksomheden blev grundlagt i 2001 og har hovedsæde i Helsingfors, Finland.